Liraglutide

Liraglutide is a long-acting GLP-1 receptor agonist originally developed for type 2 diabetes and obesity research. As a fatty acid acylated GLP-1 analog with a half-life of approximately 13 hours, it has been extensively studied for its effects on appetite regulation, glucose metabolism, cardiovascular markers, and body weight management. Every batch independently HPLC tested to 99%+ purity. COA on every order. Same-day shipping from our USA warehouse. For research use only.